Transaction · 0001817199-26-000032

Ring Christine

Ring Christine, CLO, reported a transaction classified as exercise at Nurix Therapeutics, Inc. involving 5786.000000 shares for an estimated $50453.92. Reported holdings after the transaction were 14896.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MCLO
NRIXNurix Therapeutics, Inc.
Filing timeOct 02
Trade dateOct 02, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableCalculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$22.99
Pre-filing
1mo ago +12.3%1w ago +0.1%1d ago +1.5%
Returns since
7d30d90d180d1y

NRIX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
NRIX since 2026-10-02Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001817199-26-000032
Common Stock
Transaction date
Oct 02, 2026
Filed Oct 02, 2026, 09:21 PM · 0d delay
Shares
5.78k sh
$8.72 per share
Estimated value
$50.4k
Computed from shares × price
Holdings after
14.8k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Increase 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Legal Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

  2. F2

    Represents the weighted average sale price. The lowest price at which shares were sold was $22.84 and the highest price at which shares were sold was $23.65. The Reporting Person undertakes to provide…

  3. F3

    The stock option vests as to 1/36 of the total shares monthly beginning March 13, 2024, until the option is fully vested on February 13, 2027, subject to the Reporting Person's provision of service to…

Original filing · 0001817199-26-000032
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

NRIX